BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15743388)

  • 1. Relationship between protein O-linked glycosylation and insulin-stimulated glucose transport in rat skeletal muscle following calorie restriction or exposure to O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate.
    Arias EB; Cartee GD
    Acta Physiol Scand; 2005 Mar; 183(3):281-9. PubMed ID: 15743388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged incubation in PUGNAc results in increased protein O-Linked glycosylation and insulin resistance in rat skeletal muscle.
    Arias EB; Kim J; Cartee GD
    Diabetes; 2004 Apr; 53(4):921-30. PubMed ID: 15047606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.
    Park SY; Ryu J; Lee W
    Exp Mol Med; 2005 Jun; 37(3):220-9. PubMed ID: 16000877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective effects of PUGNAc on cardiac function after trauma-hemorrhage are mediated via increased protein O-GlcNAc levels.
    Zou L; Yang S; Hu S; Chaudry IH; Marchase RB; Chatham JC
    Shock; 2007 Apr; 27(4):402-8. PubMed ID: 17414423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucosamine modulates TNF-α-induced ICAM-1 expression and function through O-linked and N-linked glycosylation in human retinal pigment epithelial cells.
    Chen CL; Liang CM; Chen YH; Tai MC; Lu DW; Chen JT
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2281-91. PubMed ID: 22427561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of differentially expressed proteins by treatment with PUGNAc in 3T3-L1 adipocytes through analysis of ATP-binding proteome.
    Lee JE; Park JH; Moon PG; Baek MC
    Proteomics; 2013 Oct; 13(20):2998-3012. PubMed ID: 23946262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics and PUGNAcity will overcome questioning of insulin resistance induction by nonselective inhibition of O-GlcNAcase.
    Dehennaut V; Lefebvre T
    Proteomics; 2013 Oct; 13(20):2944-6. PubMed ID: 23983178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.
    Yokoe S; Asahi M; Takeda T; Otsu K; Taniguchi N; Miyoshi E; Suzuki K
    Glycobiology; 2010 Oct; 20(10):1217-26. PubMed ID: 20484118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
    Vosseller K; Wells L; Lane MD; Hart GW
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calorie restriction increases muscle insulin action but not IRS-1-, IRS-2-, or phosphotyrosine-PI 3-kinase.
    Davidson RT; Arias EB; Cartee GD
    Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E270-6. PubMed ID: 11788357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptozotocin-induced beta-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells.
    Gao Y; Parker GJ; Hart GW
    Arch Biochem Biophys; 2000 Nov; 383(2):296-302. PubMed ID: 11185566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.
    Haltiwanger RS; Grove K; Philipsberg GA
    J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calorie restriction improves whole-body glucose disposal and insulin resistance in association with the increased adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima fatty rats.
    Park SY; Choi GH; Choi HI; Ryu J; Jung CY; Lee W
    Arch Biochem Biophys; 2005 Apr; 436(2):276-84. PubMed ID: 15797240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PUGNAc treatment leads to an unusual accumulation of free oligosaccharides in CHO cells.
    Mehdy A; Morelle W; Rosnoblet C; Legrand D; Lefebvre T; Duvet S; Foulquier F
    J Biochem; 2012 Apr; 151(4):439-46. PubMed ID: 22337894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro simulation of calorie restriction-induced decline in glucose and insulin leads to increased insulin-stimulated glucose transport in rat skeletal muscle.
    Arias EB; Cartee GD
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1782-8. PubMed ID: 17925453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthesis and biological evaluation of some carbocyclic analogues of PUGNAc.
    Scaffidi A; Stubbs KA; Vocadlo DJ; Stick RV
    Carbohydr Res; 2008 Nov; 343(16):2744-53. PubMed ID: 18804755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A divergent synthesis of 2-acyl derivatives of PUGNAc yields selective inhibitors of O-GlcNAcase.
    Stubbs KA; Zhang N; Vocadlo DJ
    Org Biomol Chem; 2006 Mar; 4(5):839-45. PubMed ID: 16493467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of O-linked GlcNAc modification on the glucose response of ChREBP.
    Sakiyama H; Fujiwara N; Noguchi T; Eguchi H; Yoshihara D; Uyeda K; Suzuki K
    Biochem Biophys Res Commun; 2010 Nov; 402(4):784-9. PubMed ID: 21036147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucosamine and glucose induce insulin resistance by different mechanisms in rat skeletal muscle.
    Han DH; Chen MM; Holloszy JO
    Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1267-72. PubMed ID: 12954597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.